You’ve seen the headlines. Now let’s break them open. Sasha-Ann Simons connects you with the people behind the stories: experts, neighbors and newsmakers who shape the city we share. It’s news, ...
The ubiquitin/proteasome-dependent proteolytic pathway is an attractive target for therapeutics because of its critical involvement in cell cycle progression and antigen presentation. However, ...